Switzerland

HackaTRON Season 5 Announces Qualifiers List

Retrieved on: 
Wednesday, December 6, 2023
TRON, BitTorrent, Non-fungible token, Web3, IOS SDK, DAO, USD, Decentralized finance, Blockchain, A.I, Cryptocurrency, Metaverse, Artistry, Switzerland

Geneva, Switzerland / November 10, 2023 / - As the curtain falls on HackaTRON Season 5, the TRON DAO team, alongside HTX Ventures and BitTorrent Chain (BTTC), reflects on a spectacular showcase of innovation that has unfurled across the blockchain landscape.

Key Points: 
  • Geneva, Switzerland / November 10, 2023 / - As the curtain falls on HackaTRON Season 5, the TRON DAO team, alongside HTX Ventures and BitTorrent Chain (BTTC), reflects on a spectacular showcase of innovation that has unfurled across the blockchain landscape.
  • This season, an exceptional alliance between visionary entities has set the stage for a hackathon that transcended the conventional, catalyzing the creation of cutting-edge solutions across various tracks including: Web3, DeFi, Artistry, Builder, and A.I.
  • HackaTRON Season 5 has attracted over 3,500 participants, enriching the blockchain ecosystem with innovative ideas.
  • Note: All prizes are issued in USDD, not USD
    *Qualifying HackaTRON Season 5 participants are eligible to receive issuance of awards in USDD.

Deputy CEO and Chief Consumer Officer Severina Pascu to depart from Sunrise

Retrieved on: 
Tuesday, September 26, 2023
Life, Switzerland, Marketing, Culture, UPC, Christoph, Virgin Media, Liberty Global, Swype, Germany, Customer service, Executive Committee, YOL, Consumer, LG, JCP Executive Committee, UPC Switzerland, Management, Orange S.A., Sunrise, Vodafone Germany, Lebara

Severina Pascu will be stepping down as Deputy CEO and Chief Consumer Officer of Sunrise, effective 1st of October 2023, and will take on an Executive Advisory role for six months.

Key Points: 
  • Severina Pascu will be stepping down as Deputy CEO and Chief Consumer Officer of Sunrise, effective 1st of October 2023, and will take on an Executive Advisory role for six months.
  • Christoph Richartz and Stefan Fuchs will succeed her as Chief Consumer Officer for Main Brand Sunrise, as well as Chief Consumer Officer for Flanker Brands respectively.
  • As a consequence of her departure, Christoph Richartz is to become a member of the Sunrise Executive Committee as Chief Consumer Officer - Sunrise Brand, taking responsibility for all activities with the main brand Sunrise.
  • After serving as Chief Marketing Officer at UPC Switzerland, he assumed the role of Chief Commercial Officer from January 2020.

FAA Taps Loft Dynamics' VR Flight Simulators to Advance Aviation Goals

Retrieved on: 
Monday, July 17, 2023
Federal Aviation Administration, Partnership, Nextgen, H145, Switzerland, NAS, WHTC, Aviation, CFR, Next Generation Air Transportation System, Research, Aircraft, Carbon, FNPT, National Airspace System, VR, FAA, National Airspace System Voice Switch, Airbus Helicopters, Robinson R22, Air Zermatt, Airbus, Virtual reality, EASA, William J. Hughes Technical Center, FTD, Airline, 3D printing

ZURICH and ATLANTIC CITY, N.J., July 17, 2023 /PRNewswire/ -- Loft Dynamics (formerly VRM Switzerland), a leader in virtual reality (VR) flight simulation devices for pilots worldwide, announced an unprecedented partnership with the Federal Aviation Administration (FAA). Loft Dynamics' simulators – the first and only VR flight simulators with regulatory approval in Europe – are now undergoing U.S. evaluation by the FAA. The FAA has selected Loft Dynamics' Airbus H125 and Robinson R22 simulators to explore, for the first time, the use of VR flight simulation technology to train pilots. Both simulators have been installed at the William J. Hughes Technical Center (WHTC), the FAA's innovation hub, where they will be used to advance national aviation safety, efficiency, capacity, and environmental sustainability goals, and to drive the evolution of the National Airspace System (NAS) toward the Next Generation Air Transportation System (NextGen).

Key Points: 
  • Loft Dynamics' simulators – the first and only VR flight simulators with regulatory approval in Europe – are now undergoing U.S. evaluation by the FAA.
  • The FAA has selected Loft Dynamics' Airbus H125 and Robinson R22 simulators to explore, for the first time, the use of VR flight simulation technology to train pilots.
  • "The adoption of VR flight simulators by international safety agencies like EASA and FAA is crucial given the current landscape.
  • The unique features and capabilities of Loft Dynamics' simulators allow the FAA to perform the research and development required to enhance vertical flight safety, pursue qualification under 14 CFR part 60, and advance NextGen goals.

Lyell Immunopharma Appoints Matthew Lang as Chief Business Officer

Retrieved on: 
Wednesday, July 5, 2023
LLP, Gilead Sciences, University, Switzerland, Kingston, Risk management, Queen's University at Kingston, Lyell, Labour law, Dechert, Classics, Employment, Organization, Acquisition, Patient, SAN, Roivant Sciences, Corporation, Growth, Information governance, Management, Pharmaceutical industry

SOUTH SAN FRANCISCO, Calif., July 05, 2023 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with solid tumors, today announced that Matthew Lang, J.D.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., July 05, 2023 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with solid tumors, today announced that Matthew Lang, J.D.
  • has joined the executive management team as Chief Business Officer.
  • In this newly created role, Mr. Lang will serve on Lyell’s executive committee and will be responsible for Lyell’s legal, compliance, human resources, alliance management and early commercialization teams.
  • He will also serve as Lyell’s Chief Legal Officer and Corporate Secretary.

Introducing ISC-CX Close the Loop powered by AI - Maximizing Customer Experiences through seamless action

Retrieved on: 
Thursday, June 29, 2023
Loop, Closing the Loop, AI, Switzerland, Electric motor, Satellite navigation device

MUNICH, Germany and BASEL Switzerland, June 29, 2023 /PRNewswire-PRWeb/ -- ISC-CX, a leading provider of customer experience solutions, is thrilled to unveil its latest product, ISC-CX Close the Loop powered by AI. This innovative self-assessment tool revolutionizes the way companies identify and rectify operational shortfalls and gaps, offering significant time and cost savings.

Key Points: 
  • ISC-CX, a leading provider of customer experience solutions, is thrilled to unveil its latest product, ISC-CX Close the Loop powered by AI.
  • MUNICH, Germany and BASEL Switzerland, June 29, 2023 /PRNewswire-PRWeb/ -- ISC-CX, a leading provider of customer experience solutions, is thrilled to unveil its latest product, ISC-CX Close the Loop powered by AI.
  • "With Close the Loop powered by AI, companies can swiftly address operational shortfalls without the need for physical interventions, saving valuable time and resources."
  • ISC-CX Close the Loop powered by AI boasts a user-friendly interface and intuitive functionalities, including native app capture, in-app photo upload, geotracking, and an easily navigable user journey.

LanzaTech and Plastipak Partner to Produce World’s First PET Resin Made from Waste Carbon

Retrieved on: 
Thursday, May 18, 2023
Carbon accounting, Partnership, Food, Petroleum, Drink, Climate, Life, Switzerland, Gas, Aviation, Electricity, Clothing, CCT, PET, Recycling, Carbon, Aviation biofuel, Climate change, MEG, Migros, Greenhouse

The resin is suitable for food, personal care, and pharmaceutical packaging, as well as other non-packaging applications.

Key Points: 
  • The resin is suitable for food, personal care, and pharmaceutical packaging, as well as other non-packaging applications.
  • PET resin comprises 30% monoethylene glycol (MEG) traditionally derived from petroleum.
  • It retains the technical properties of virgin fossil PET while carrying a lower carbon footprint.
  • “We are delighted to partner with LanzaTech to achieve early progress in our ambition to produce PET with lower environmental impacts.

Molecure Announces Full Year Financial 2022 Results – A Year of Significant Progress

Retrieved on: 
Thursday, March 30, 2023
ARG1, Sarcoidosis, Financial Oversight and Management Board for Puerto Rico v. Aurelius Investment, LLC, CET, Therapy, Medical device, American Association for Cancer Research, NASH, Switzerland, Clinical trial, European Directive on Traditional Herbal Medicinal Products, Cancer, CTA, RNA, Inflammation, Language, EMA, Fibrosis, Biocidal Products Directive, Congress, Patient, Vicki Belo, Interstitial lung disease, ARG2, Biology, Growth, Fatty liver disease, MOC, FDA, Leukemia, IPF, Molecular Cancer Research, Idiopathic pulmonary fibrosis, Safety, Disease, Pharmaceutical industry, Cryptocurrency, MD, Polish

“Molecure has made significant progress over 2022, becoming a clinical stage biotechnology company preparing our two most advanced assets to start multi-center phase I and phase II studies respectively” said Marcin Szumowski, CEO and President of the Management Board of Molecure.

Key Points: 
  • “Molecure has made significant progress over 2022, becoming a clinical stage biotechnology company preparing our two most advanced assets to start multi-center phase I and phase II studies respectively” said Marcin Szumowski, CEO and President of the Management Board of Molecure.
  • In recent weeks, we achieved an important milestone dosing the first cancer patient in a Phase I study with OATD-02, the first and only dual arginase inhibitor.
  • The Company's full year presentation to investors will be held on April 5, 2023 at 2:00 PM (CET) in an online meeting.
  • In 2022, Molecure announced a new name and brand identity.

Iktos raises € 15.5m Series A round to expand its artificial intelligence-based drug discovery technologies and solutions

Retrieved on: 
Thursday, March 9, 2023
Peptide, Wuhan Institute of Biological Products, Robotics, Intelligence, Antibody, Janssen, Merck Group, Software as a service, Drug discovery, Probability, Drug development, Series, Merck, Switzerland, Automation, Medical device, Pharmaceutical industry, Teijin, Pfizer

This financing will enable the company to further develop its AI and drug discovery capabilities and expand its existing SaaS software offering, in addition to launching Iktos Robotics; a unique, end-to-end, drug discovery platform which combines artificial intelligence and automation of chemical synthesis to significantly accelerate drug discovery timelines.

Key Points: 
  • This financing will enable the company to further develop its AI and drug discovery capabilities and expand its existing SaaS software offering, in addition to launching Iktos Robotics; a unique, end-to-end, drug discovery platform which combines artificial intelligence and automation of chemical synthesis to significantly accelerate drug discovery timelines.
  • Within the financing Iktos will additionally extend the application of its solutions to biological products (peptides, antibodies, etc.).
  • This allows Iktos to be one of the first companies to offer fully integrated drug discovery services to the pharmaceutical industry.
  • The artificial intelligence solutions developed by Iktos are aimed to considerably speed up the drug discovery process, while increasing the probability of success of drug candidates reaching clinical development.

EQS-News: fox e-mobility AG publishes annual figures for 2021 and pushes ahead with restructuring

Retrieved on: 
Sunday, December 18, 2022
Annual report, Extraordinary general meeting, Marketing, Switzerland, Federal Gazette (Switzerland), PLC, Maintenance, ISIN, Federal Gazette, Supervisory board, Annual, Annual general meeting, MIA, Security (finance), Euronext

Munich, 16 December 2022. fox e-mobility AG (ISIN DE000A2NB551), a European electric vehicle company specializing in the production, marketing and development of compact electric cars in the lower price segment, publishes its audited annual figures for the 2021 financial year.

Key Points: 
  • Munich, 16 December 2022. fox e-mobility AG (ISIN DE000A2NB551), a European electric vehicle company specializing in the production, marketing and development of compact electric cars in the lower price segment, publishes its audited annual figures for the 2021 financial year.
  • The Supervisory Board today approved the annual financial statements and set the date for the Annual General Meeting for 31 January 2023.
  • The development of the restructuring plan and the scheduling of the Annual General Meeting are important steps on this path."
  • Management is developing a restructuring plan which will be outlined to shareholders at the Annual General Meeting scheduled for 31 January 2023.

SYNLAB and Microba reinforce their combined expertise and expand strategic agreement on advanced gut microbiome test myBIOME

Retrieved on: 
Friday, October 28, 2022
Biotechnology, General Health, Health, Pharmaceutical, Oncology, NGS, Acquisition, Switzerland, DNA, DNA sequencing, Group, Disease, Hospital, MAP, Bacteria, Conditional sentence, Patient, Synlab Group, Quality of life, Archaea, ASX, Genetics, Health, Fungus, Dietary supplement, Medical device, Antibiotics

SYNLAB, the leader in medical diagnostic services and specialty testing in Europe, and Microba Life Sciences (Microba), a global leader in the analysis of complex gut microbiomes, have expanded their strategic agreement to broaden geographic and market availability of the microbiome test myBIOME across Europe and Latin America.

Key Points: 
  • SYNLAB, the leader in medical diagnostic services and specialty testing in Europe, and Microba Life Sciences (Microba), a global leader in the analysis of complex gut microbiomes, have expanded their strategic agreement to broaden geographic and market availability of the microbiome test myBIOME across Europe and Latin America.
  • myBIOME is the most complete and accurate metagenomic sequencing test available on the market today, allowing for a comprehensive, highly differentiated and actionable analysis of an individuals gut microbiome.
  • Applying game-changing metagenomic technology developed by Microba, myBIOME detects all types of microorganisms (bacteria, archaea, fungi, protists), identifies the exact species and characterises new species.
  • Microba Life Sciences (ASX: MAP) is a precision microbiome company driven to improve human health.